RELVAR ELLIPTA SIGNIFICANTLY IMPROVED ASTHMA CONTROL IN SALFORD LUNG STUDY PATIENTS COMPARED WITH THEIR USUAL CARE
Journal Title: Pulmonologija ir alergologija - Year 2017, Vol 1, Issue 2
Abstract
Salford Lung Study is an open-label, randomised, controlled, two-arm effectiveness trial at general practice clinics. In patients with symptomatic asthma and on maintenance inhaler therapy, initiation of a once-daily treatment regimen of combined fluticasone furoate and vilanterol (Relvar Ellipta) for 52 weeks improved asthma control without increasing the risk of serious adverse events when compared with optimised usual care.
Authors and Affiliations
Kęstutis Malakauskas
Keywords
Related Articles
- EP ID EP266206
- DOI -
- Views 147
- Downloads 0
COMPREHENSIVE GENOMIC PROFILING IN DIAGNOSTIC OF LUNG CANCER
Diagnosis of lung cancer should be confirmed morphologically and TNM stage must be established. Now systemic treatment of lung cancer should be personalized on the basis on tumor molecular properties, specifically on tar...
THE ROLE OF FIBROBLAST IN DEVELOPMENT OF AIRWAY REMODELING IN ASTHMA
Airway remodeling is an important component of the structural changes of airways seen in asthma. Fibroblasts are mesenchymal stem cells found in organism at non-contractile fibroblasts form or at contractility properti...
INHALED TRIPLE THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: TRIBUTE CLINICAL STUDY DATA
Chronic obstructive pulmonary disease (COPD) is characterised by persistent respiratory symptoms and airflow limitation. Due to disease severity, exacerbations, exacerbations, affecting the quality of life,...
PRINCIPLES OF DIAGNOSTIC IMAGING OF ACUTE PULMONARY INFECTIONS
Pulmonary infections are not only among the most common clinical situations, encountered in outpatient and inpatient clinical care, that have high impact on patient health status, treatment and outcomes, b...
DIAGNOSIS AND TREATMENT OF CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION
Chronic thromboembolic pulmonary hypertension (CTEPH) is a distinct form of pulmonary hypertension due to chronic obstruction of the pulmonary artery tree. If left untreated, the prognosis is poor. Pulmonary endarterect...